Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 23, 2010

View Archived Issues

Kalypsys claims new GPR119 receptor agonists

Pulmagen Therapeutics discovers new inhibitors of neutrophil elastase

Boehringer Ingelheim discovers novel chymase inhibitors

Phosphoprofiling approach identifies drug-specific biomarkers of PI3K pathway inhibition

Meta-analysis reveals potential link between ARBs and onset of cancer

GCC-2680 shows promise as obesity therapeutic based on preclinical data

Amsterdam Molecular Therapeutics provides update on Glybera MAA

Anchor Therapeutics secures funds to advance pepducin drug candidates

Bioniche provides development update on Urocidin in bladder cancer

Bolder BioTech receives grant to study IL-11 analogue for acute radiation syndrome

Protalex treats first patient in phase Ib PRTX-100 trial in RA

SkyePharma regains U.S. rights to Flutiform for asthma

ADDF funds Cognition Therapeutics to advance AD candidate

ISCO provides update on stem cell-based eye care programs

Scientists link clozapine-induced myocarditis to obesity, creatinine kinase and C-reactive protein

FDA extends review of Acetadote sNDA for non-acetaminophen acute liver failure

EpiCept receives refusal to file letter from FDA for Ceplene NDA

Scientists identify new pathway of tricarboxylic acid metabolism in P. falciparum

Precedex IV 200 mcg approved for long-term use in Japan

New DGAT-1 inhibitors claimed by Banyu Pharmaceutical

Pfizer discloses new inhibitors of DGAT-1

FDA advisory committee votes against use of JZP-6 for fibromyalgia

FDA continues safety review of Stalevo and possible increased cardiovascular risk

University of Pittsburgh receives donation for stem cell research on corneal scarring

GSK begins phase III trials of herpes zoster vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...